UK MHRA–NICE pathway to create faster regulatory approval

The Lancet Oncology 2026

View at publisher
Authors: Elizabeth Gourd
DOI: 10.1016/s1470-2045(26)00183-x
Cited by: 1

Fields of Study & Subjects

Health Systems Economic Evaluations Quality of Life Animal testing and alternatives Pharmacovigilance and Adverse Drug Reactions

Publication details

Journal / source
The Lancet Oncology
Publisher
Elsevier BV
Volume
27
Issue
5
Pages
546–546
Publication date
11 April 2026
Language
EN